Clinical trial
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients…
NCT00055601 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00055601 |
|---|---|
| Title | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer |
| Official title | A Phase II Randomized Trial for Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery and BID Irradiation Plus Either Paclitaxel and Cisplatin or 5-Fluorouracil and Cisplatin Followed by Selective Bladder Preservation and Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group NRG Oncology |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, fluorouracil, paclitaxel, radiation therapy, Gemcitabine, Radical cystectomy |
| Enrollment | 97 |
| Start date | Dec 1, 2002 |
| Primary completion | Oct 1, 2010 |
| Completion | May 14, 2018 |
| First posted | Mar 7, 2003 |
| Last update posted | Jun 15, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: